World's Best Scientists 2026 revealed!
Amanda E. I. Proudfoot

Amanda E. I. Proudfoot

D-Index & Metrics

Immunology

D-Index
98
Citations
34023
World Ranking
789
National Ranking
51

Amanda E. I. Proudfoot publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Amanda E. I. Proudfoot sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 251 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Amanda E. I. Proudfoot D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Amanda E. I. Proudfoot sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Amanda E. I. Proudfoot was affiliated with Merck (Germany) in Germany. Their research primarily focused on the biology and pharmacology of chemokine receptors, which are critical in cell signaling pathways related to immune response and cancer. Throughout their career, they contributed to multiple publications in a specialized field of Medicine, particularly within Oncology and Immunology subfields.

Their recent publications consistently appeared in the venue IUPHAR/BPS Guide to Pharmacology CITE, marking a clear focus on high-quality pharmacological databases and reviews related to chemokine receptors. The following papers document their continued involvement over several years:

  • Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database, 2020, IUPHAR/BPS Guide to Pharmacology CITE
  • Chemokine receptors in GtoPdb v.2023.1, 2023, IUPHAR/BPS Guide to Pharmacology CITE
  • Chemokine receptors in GtoPdb v.2025.1, 2025, IUPHAR/BPS Guide to Pharmacology CITE
  • Chemokine receptors in GtoPdb v.2025.3, 2025, IUPHAR/BPS Guide to Pharmacology CITE

Their scholarly work concentrated on several main topics:

  • Chemokine receptors and signaling
  • Immune cells in cancer
  • Cytokine Signaling Pathways and Interactions

Throughout their career, Amanda E. I. Proudfoot collaborated frequently with a group of coauthors who appeared repeatedly in their publications:

  • Françoise Bachelerie
  • Adit Ben-Baruch
  • Amanda M. Burkhardt
  • Israel Charo
  • Christophe Combadière

Their contributions advanced the understanding of chemokine receptor biology within the contexts of immune modulation and cancer. By participating in the curation and updating of pharmacological databases, they provided reference points widely used within the scientific community studying receptor signaling.

Best Publications

  • Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

    Amanda E. I. Proudfoot;Tracy M. Handel;Zoë Johnson;Elaine K. Lau

  • International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

    Francoise Bachelerie;Adit Ben-Baruch;Amanda M. Burkhardt;Christophe Combadiere

  • Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist

    Graham Simmons;Paul R. Clapham;Laurent Picard;Robin E. Offord

  • Lymph-Borne Chemokines and Other Low Molecular Weight Molecules Reach High Endothelial Venules via Specialized Conduits While a Functional Barrier Limits Access to the Lymphocyte Microenvironments in Lymph Node Cortex

    J. Elizabeth Gretz;Christopher C. Norbury;Arthur O. Anderson;Amanda E.I. Proudfoot

  • Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

    Christophe Combadière;Stéphane Potteaux;Mathieu Rodero;Tabassome Simon

  • RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.

    Clare M. Lloyd;Andrew W. Minto;Martin E. Dorf;Amanda Proudfoot

  • Chemokine receptors: multifaceted therapeutic targets

    Unknown

  • HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

    Milena Schiraldi;Angela Raucci;Laura Martínez Muñoz;Elsa Livoti

  • RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium

    Philipp von Hundelshausen;Philipp von Hundelshausen;Philipp von Hundelshausen;Kim S. C. Weber;Kim S. C. Weber;Kim S. C. Weber;Yuqing Huo;Yuqing Huo;Yuqing Huo;Amanda E. I. Proudfoot;Amanda E. I. Proudfoot;Amanda E. I. Proudfoot

  • Regulation of protein function by glycosaminoglycans- : As exemplified by chemokines

    T M Handel;Z Johnson;S E Crown;E K Lau

  • Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.

    Gabriele S. V. Kuschert;Florence Coulin;Christine A. Power;Amanda E. I. Proudfoot

  • The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness

    Jose-Angel Gonzalo;Clare M. Lloyd;Danyi Wen;Juan P. Albar

  • Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines

    Arlene J. Hoogewerf;Gabriele S. V. Kuschert;Amanda E. I. Proudfoot;Frederic Borlat

  • CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin

    Yvonne Reiss;Amanda E. Proudfoot;Christine A. Power;James J. Campbell

  • Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice

    Matthias Mack;Josef Cihak;Christopher Simonis;Bruno Luckow

  • Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist

    Amanda E.I. Proudfoot;Christine A. Power;Arlene J. Hoogewerf;Marc-Olivier Montjovent

  • Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity

    Matthias Mack;Bruno Luckow;Peter J. Nelson;Josef Cihak

  • Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

    Niels R. Veillard;Brenda Kwak;Graziano Pelli;Flore Mulhaupt

  • Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium

    Philipp von Hundelshausen;Rory R. Koenen;Markus Sack;Sebastian F. Mause

  • Overcoming hurdles in developing successful drugs targeting chemokine receptors

    Unknown

  • Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line

    Christine A. Power;Alexandra Meyer;Karin Nemeth;Kevin B. Bacon

  • HIV-1 Tat protein mimicry of chemokines

    Adriana Albini;Silvano Ferrini;Roberto Benelli;Sabrina Sforzini

  • Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells

    Christine A. Power;Dennis J. Church;Alexandra Meyer;Sami Alouani

Frequent Co-Authors

Christine A. Power
Christine A. Power Merck Serono (Italy)
Timothy N. C. Wells
Timothy N. C. Wells Cardiff University
Paul R. Clapham
Paul R. Clapham University of Massachusetts Chan Medical School
Tracy M. Handel
Tracy M. Handel University of Montana
Christian Weber
Christian Weber Ludwig-Maximilians-Universität München
Matthias Mack
Matthias Mack University of Regensburg
Alain Bernard
Alain Bernard Grenoble Alpes University
Manuel C. Peitsch
Manuel C. Peitsch Philip Morris International (United States)
Mauro M. Teixeira
Mauro M. Teixeira Universidade Federal de Minas Gerais

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with healthcare fields where advanced nursing skills play a critical role. For many, exploring accelerated NP programs offers a faster route to becoming a nurse practitioner with specialized knowledge to support immunology-related patient care. These programs are designed for experienced nurses ready to advance their clinical skills.

For those without a nursing background but interested in entering healthcare connected to immunology, online nursing programs for non nurses provide flexible and accessible pathways. These programs prepare students for nursing roles that complement immunology research and practice.

Similarly, accelerated BSN programs for non nurses are popular options for quickly obtaining a Bachelor of Science in Nursing, enabling graduates to work directly with immunological treatments and research teams. Their accelerated nature makes them an attractive choice for career changers.

For those just starting out in the healthcare field, LPN programs easy to get into offer an entry-level nursing credential. Licensed Practical Nurses often support immunology departments by providing basic patient care and assisting with immunization programs.

Best Scientists Citing Amanda E. I. Proudfoot

Recently Published Articles